Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Syros Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- +5 vs. Q3 2022
- Shares held
- 10.6M
- +1.26M (+13.5%) vs. Q3 2022
- Total value
- $37.9M
- −$22.0M (−36.7%) vs. Q3 2022
- New holders
- 14
- 12 more added
- Sold out
- 9
- 14 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SYRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $12.4K |
| Q4 2024 | 44 | $1.20M |
| Q3 2024 | 65 | $40.8M |
| Q2 2024 | 70 | $105.2M |
| Q1 2024 | 75 | $111.9M |
| Q4 2023 | 58 | $146.8M |
| Q3 2023 | 48 | $47.9M |
| Q2 2023 | 53 | $33.5M |
| Q1 2023 | 59 | $27.5M |
| Q4 2022 | 57 | $37.9M |
| Q3 2022 | 53 | $59.9M |
| Q2 2022 | 69 | $34.2M |
| Q1 2022 | 94 | $53.1M |
| Q4 2021 | 90 | $166.0M |
| Q3 2021 | 100 | $223.1M |
| Q2 2021 | 100 | $276.0M |
| Q1 2021 | 106 | $475.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Syros Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CarsonAllaria Wealth Management, Ltd. | 104 | $0 | 0.00% | −58−35.8% | Reduced |
| Royal Bank of Canada | 7 | $0 | 0.00% | −29−80.6% | Reduced |
| GWM Advisors LLC | 15 | $0 | 0.00% | +15 | New |
| FMR LLC | 12 | $43 | 0.00% | −252,017−100.0% | Reduced |
| Heritage Wealth Management, LLC | 36 | $129 | 0.00% | +18+100.0% | Added |
| US Bancorp | 40 | $144 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 87 | $312 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 129 | $463 | 0.00% | 00.0% | Unchanged |
| Ten Capital Wealth Advisors, LLC | 219 | $786 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 223 | $1.00K | 0.00% | −510−69.6% | Reduced |
| JPMorgan Chase & Co | 596 | $2.00K | 0.00% | −116−16.3% | Reduced |
| Wells Fargo & Company | 700 | $2.51K | 0.00% | +1+0.1% | Added |
| Russell Investments Group, Ltd. | 750 | $2.69K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 1,095 | $3.93K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,289 | $4.00K | 0.00% | +1,289 | New |
| Bank of America Corp | 1,149 | $4.13K | 0.00% | −7−0.6% | Reduced |
| Federated Hermes, Inc. | 1,217 | $4.37K | 0.00% | −22,669−94.9% | Reduced |
| Group One Trading, L.P. | 1,376 | $4.94K | 0.00% | +310+29.1% | Added |
| IFP Advisors, Inc | 793 | $6.00K | 0.00% | +743+1,486.0% | Added |
| Edmond de Rothschild Holding S.A. | 4,382 | $15.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,842 | $24.6K | 0.00% | −2,827−29.2% | Reduced |
| Denali Advisors LLC | 7,700 | $27.6K | 0.01% | +7,700 | New |
| Two Sigma Investments, LP | 10,461 | $37.6K | 0.00% | +10,461 | New |
| Tower Research Capital LLC (TRC) | 12,062 | $43.0K | 0.00% | +9,410+354.8% | Added |
| Price T Rowe Associates Inc | 12,150 | $44.0K | 0.00% | +12,150 | New |
| Goldman Sachs Group Inc | 12,408 | $44.5K | 0.00% | +12,408 | New |
| Virtu Financial LLC | 12,428 | $45.0K | 0.01% | +12,428 | New |
| Prelude Capital Management, LLC | 14,399 | $51.7K | 0.00% | +14,399 | New |
| HighTower Advisors, LLC | 15,004 | $53.0K | 0.00% | +15,004 | New |
| Northern Trust Corp | 15,203 | $54.6K | 0.00% | −30.0% | Reduced |
| Jane Street Group, LLC | 16,319 | $58.6K | 0.00% | +16,319 | New |
| Acadian Asset Management LLC | 17,742 | $62.0K | 0.00% | −6,823−27.8% | Reduced |
| Ergoteles LLC | 18,181 | $65.3K | 0.00% | +18,181 | New |
| Clarius Group, LLC | 18,620 | $67.0K | 0.01% | −727−3.8% | Reduced |
| 1492 Capital Management LLC | 21,744 | $78.1K | 0.05% | +21,744 | New |
| Dimensional Fund Advisors LP | 30,226 | $109.0K | 0.00% | +702+2.4% | Added |
| State Street Corp | 33,130 | $118.9K | 0.00% | −20.0% | Reduced |
| ExodusPoint Capital Management, LP | 34,165 | $123.0K | 0.00% | +34,165 | New |
| LPL Financial LLC | 40,980 | $147.1K | 0.00% | +29,145+246.3% | Added |
| Susquehanna International Group, LLP | 43,247 | $155.3K | 0.00% | +33,042+323.8% | Added |
| Renaissance Technologies LLC | 47,235 | $170.0K | 0.00% | +3,500+8.0% | Added |
| LGT Capital Partners Ltd. | 55,000 | $197.4K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 70,516 | $253.0K | 0.00% | +101+0.1% | Added |
| Millennium Management LLC | 91,473 | $328.0K | 0.00% | +21,839+31.4% | Added |
| BlackRock Inc. | 207,719 | $745.7K | 0.00% | −37,514−15.3% | Reduced |
| Omega Fund Management, LLC | 251,270 | $902.1K | 0.30% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 265,878 | $954.5K | 0.27% | 00.0% | Unchanged |
| Altium Capital Management LP | 315,070 | $1.13M | 0.58% | +315,070 | New |
| CVI Holdings, LLC | 425,500 | $1.53M | 0.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 472,730 | $1.70M | 0.00% | −14,803−3.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 721,914 | $2.59M | 0.01% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 868,403 | $3.12M | 3.03% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 881,450 | $3.16M | 0.68% | 00.0% | Unchanged |
| Avidity Partners Management LP | 900,000 | $3.23M | 0.08% | 00.0% | Unchanged |
| Flagship Pioneering Inc. | 993,848 | $3.57M | 0.11% | 00.0% | Unchanged |
| Artal Group S.A. | 1,463,829 | $5.25M | 0.30% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 2,124,694 | $7.63M | 0.85% | +1,042,290+96.3% | Added |
| Pathstone Family Office, LLC | 0 | $0 | 0.00% | −21,913−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −12,800−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −502−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |